Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Omicron

The latest COVID booster will soon be available. Should I get one? Am I eligible?

Australia’s Therapeutic Goods Administration (TGA) has recently approved a new COVID booster. The shot was developed by Pfizer and targets the JN.1 sub-variant of Omicron.

The Conversation

Britain has closed its eyes to long Covid – which means it will ravage even more lives and livelihoods

Unlike the US, Canada and Australia, the UK is only giving free boosters to some. But the cost of restricting them could be huge, says Devi Sridhar of Edinburgh University

The Guardian - UK

XEC is now in Australia. Here’s what we know about this hybrid COVID variant

Over the nearly five years since COVID first emerged, you’d be forgiven if you’ve lost track of the number of new variants we’ve seen. Some have had a bigger impact than others, but virologists have documented thousands.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Will the XEC COVID subvariant bring a fall wave of infections? What to know about symptoms and spread

The U.S. is coming down from its biggest COVID summer surge yet as a new subvariant emerges—but new vaccines are here, too.

Fortune

New Covid XEC variant starting to spread in Europe – what we know about signs and symptoms

More contagious virus is sublineage of omicron variant, scientists say

The Independent UK

Updated COVID mRNA Vaccines Get FDA Approval: Here's What To Know

The updated COVID shots from Pfizer-BioNTech and Moderna target the current KP.2 strain of SARS-CoV-2, a descendant of the highly contagious Omicron subvariant JN.1.

Medical Daily

LB.1, or D-FLiRT, is the newest COVID subvariant. What do we know about it? Where has it come from?

Headlines are again warning of a new COVID variant in Australia. This time it’s LB.1, or as some experts have dubbed it, “D-FLiRT”.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants

These JN.1 spinoffs are more immune-evasive than subvariants past, scientists say.

Fortune

As COVID cases rise again, what do I need to know about the new FLiRT variants?

We’ve now been living with COVID for well over four years. Although there’s still much to learn about SARS-CoV-2 (the virus that causes COVID) at least one thing seems clear: it’s here to stay.

The Conversation

Alarm bells ring as Covid situation worsens

Experts are becoming concerned about the worsening Covid-19 situation over the past weeks, with health authorities issuing warnings on the spread of the new Omicron sub-variants.

Bangkok Post

Dollar Pauses As Investors Assess US Rates Outlook

US dollar rally pauses as investors reassess Fed rate hike expectations amidst Omicron concerns.

Top News

US CDC Updates COVID Isolation Guidelines To Five Days

CDC updates COVID-19 isolation guidelines to 5 days due to Omicron variant. Learn more about the new recommendations and preventive measures.

Zenger

Omicron Infection Boosts Immune System, Protects Against Future COVID Variants: Study

People infected with Omicron develop strong immune response, reducing risk of severe symptoms from future strains.

The Guardian - US

Mask policies return in US as respiratory viruses threaten to strain hospitals

Covid, flu and RSV rates creep up as vaccination rates for all three remain low, worrying healthcare providers

The Hindu

COVID-19: Karnataka reports 175 more JN.1 cases, taking total to 374

After reporting 34 cases of JN.1 on December 25 and 165 cases on January 1, an additional 175 people from Karnataka are found to be infected with the highly transmissible new sub-variant of Omicron. With this, the total JN.1 cases in the State has now touched 374.

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

COVID could evolve to become more severe

JN.1's parent can infect lung cells more efficiently, a mutation that's different from the "milder" Omicron

The Canberra Times

It comes as the ACT plans to stop recording COVID numbers.

Fortune

New, highly mutated COVID variants ‘Pirola’ BA.2.86 and JN.1 may cause more severe disease, new studies suggest

“We cannot ignore the evidence” that Omicron may be evolving into a more severe form of itself, one researcher told Fortune.

Fortune

Why hasn't the WHO assigned a Greek letter to JN.1 "Pirola"? How it decides when to name COVID-19 variants

In an exclusive interview with Fortune, the WHO's COVID-19 lead said the organization is ready to assign a new Greek letter on a moment’s notice, but is holding out for a variant that's "truly different." Not all experts agree with the approach.

The Hindu

Responding to the new COVID-19 sub-variants, now and in future

India needs to interpret the rise in COVID-19 cases more carefully also keeping in mind that it is time we handle SARS-CoV-2 or COVID-19 just like any other respiratory illness

Fortune

COVID-19 variant JN.1 symptoms: Is ‘Pirola’ different from other Omicron spawn?

Is “Pirola” JN.1 turning COVID into a gastrointestinal illness? For some people, it’s always been one.

Medical Daily

Hospital Admissions For Pediatric RSV Far Higher Than Omicron Or Flu: Study

The study showed that in children, the hospitalization rate was highest for RSV (81.7%), while it was only 31.5% for omicron and 27.7% for influenza.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Ohio State University

84 stories

PfizerBioNTech

31 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.